UNSPSC 51101671: Phanquinone or phanquone

This classification denotes a topical anti-infective agent and antiprotozoal agent with the molecular formula C12H6N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ID94IS6N8J, chemically known as 4,7-phenanthroline-5,6-quinone but generally known as phanquinone, which bears US NIH Compound Identifier 6764. European Medicines Agency schedules Phanquinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09742MIG.

UNSPSC 51101671 Phanquinone or phanquone is a Commodity code that does not align with the recent state and local procurement activity tagged to it. The most recent opportunities in the source show pharmaceutical supply contracts for antibiotics and naloxone rather than phanquinone, indicating a mismatch between the code's nominal scope and what is actually being procured under this UNSPSC designation in state and local markets. The Illinois Department of Public Health awarded a piggyback contract through the MMCAP Infuse consortium for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets, while Seminole County, Florida released an Invitation for Bid for Naloxone and Safe Drug Deactivation Systems. These represent emergency response and public health pharmaceutical procurement rather than specialty chemical compounds.

State and local activity under this code shows limited and geographically scattered recent momentum. Illinois and Florida account for the two most recent recorded opportunities, both completed or closed as of mid-2026. The Illinois Department of Public Health awarded $2.999 million over three years to Chartwell Rx LLC through the MMCAP Infuse piggyback vehicle in an Invitation for Bid process closed in August 2026, while Seminole County's naloxone procurement on an IFB basis closed in July 2023. No open solicitations supporting this code appear in the current pipeline. Given the disconnect between the code definition and the pharmaceuticals actually being purchased, prospects pursuing activity under this UNSPSC designation should verify procurement intent directly with issuing bodies rather than relying on code classification alone.